ID   GBM8401
AC   CVCL_B051
SY   GBM-8401; GBM 8401; GBM8401/TSGH,NDMC; GlioBlastoma Multiforme 1984 No. 1/Tri-Service General Hospital,National Defense Medical Center
DR   BTO; BTO:0003879
DR   BCRC; 60163
DR   Cosmic; 1237539
DR   Wikidata; Q54835479
RX   PubMed=1657334;
RX   PubMed=2839737;
RX   PubMed=33952458;
CC   Population: Chinese.
CC   Doubling time: ~38 hours (PubMed=2839737).
CC   Omics: Transcriptome analysis by RNAseq.
CC   Derived from site: In situ; Brain, right parietal lobe; UBERON=UBERON_0002803.
ST   Source(s): BCRC
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 8,9
ST   D16S539: 12,13
ST   D5S818: 11,13
ST   D7S820: 11,12
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 14
//
RX   PubMed=1657334;
RA   Lee W.-H., Tu Y.-C.;
RT   "Scanning electron microscopic study of three glioblastoma multiforme
RT   (GBM) cell lines of the Chinese brain in vitro and in vivo.";
RL   Zhonghua Yi Xue Za Zhi (Taipei) 48:177-184(1991).
//
RX   PubMed=2839737; DOI=10.1002/jso.2930380309;
RA   Lee W.-H., Yeh M.-Y., Tu Y.-C., Han S.-H., Wang Y.-C.;
RT   "Establishment and characterization of a malignant glioma cell line,
RT   GBM8401/TSGH,NDMC.";
RL   J. Surg. Oncol. 38:173-181(1988).
//
RX   PubMed=33952458; DOI=10.21873/anticanres.15008;
RA   Ha H.-A., Yang J.-S., Tsai F.-J., Li C.-W., Cheng Y.-D., Li J.-Y.,
RA   Hour M.-J., Chiu Y.-J.;
RT   "Establishment of a novel temozolomide resistant subline of
RT   glioblastoma multiforme cells and comparative transcriptome analysis
RT   with parental cells.";
RL   Anticancer Res. 41:2333-2347(2021).
//